Moderna will rally more than 42%? Here are 10 more price target changes for Monday

Morgan Stanley cut the VTEX VTEX price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from overweight to equal weight. Shares of VTEX fell 4.9% to close at $3.52 on Friday. Keybanc reduced Progyny, Inc. PGNY's price target from $55 to $45. Keybanc analyst Scott Schoenhaus maintained an overweight rating on the stock. Progyny gained 4.1% to close at $31.83 on Friday. SVB Leerink has raised the price target on Roivant Sciences Ltd. ROIV from $8 to $10. SVB Leerink analyst David Risinger maintained an outperform rating for the stock. Shares of Roivant Sciences gained 1.1% to close at $7.32 on Friday. Raymond James raised the W. P. Carey Inc. WPC price target from $80 to $85. Raymond James analyst RJ Milligan maintained an outperform rating for the stock. Shares of W.P. Carey fell 0.1% to $79.73 in premarket trading. Needham raised AtriCure, Inc.'s ATRC price target from $55 to $58. Needham analyst Mike Matson maintained a buy rating on the stock. Shares of AtriCure fell 2.6% to close at $41.37 on Friday. JP Morgan cut Glaukos Corporation GKOS price target from $48 to $42. JP Morgan analyst Allen Gong took the stock from underweight to neutral. Glaukos shares rose 0.8% to $42.83 in premarket trading. Jefferies raised Moderna, Inc.'s MRNA price target from $170 to $275. Jefferies analyst Michael Yee moved the stock from Hold to Buy. Moderna shares fell 6.7% to close at $193.29 on Friday. Stifel lowered the Xylem Inc. XYL price target from $113 to $115. 170. Stifel analyst Nathan Jones downgraded the stock from Buy to Hold. Shares of Xylem fell 0.6% to $109.27 in premarket trading. Piper Sandler raised ConocoPhillips' COP price target from $155 to $157. Piper Sandler analyst Ryan Todd maintained an overweight rating on the stock. Shares of ConocoPhillips rose 1% to $111.50 in premarket trading. HC Wainwright & Co. raised Astria Therapeutics, Inc.'s ATXS price target from $13 to $20. HC Wainwright & Co. analyst Joseph Pantginis held the stock at a buy rating. Shares of Astria Therapeutics jumped 4.8% to close at $11.81 on Friday. Baird reduced the target price of L3Harris Technologies, Inc. LHX from $290 to $241. Baird analyst Peter Arment downgraded the stock from Outperform to Neutral. Shares of L3Harris Technologies fell 1.5% to $210.00 in premarket trading.

Check this out: 4 Penny Stocks insiders are buying: Getaround, Corvus Pharmaceuticals, etc.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.